key: cord-0823068-lsgsdghc
authors: Sentilhes, Loïc; De Marcillac, Fanny; Jouffrieau, Charlotte; Kuhn, Pierre; Thuet, Vincent; Hansmann, Yves; Ruch, Yvon; Fafi-Kremer, Samira; Deruelle, Philippe
title: COVID-19 in pregnancy was associated with maternal morbidity and preterm birth
date: 2020-06-15
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.06.022
sha: ea1368768d2170d7ef7ba01a8cf053e1104a4539
doc_id: 823068
cord_uid: lsgsdghc

Abstract Background Despite the mainly reassuring outcomes for pregnant women with COVID-19 infection reported by previous case series with small sample sizes, some recent reports of severe maternal morbidity requiring intubation and of maternal deaths show the need for additional data about the impact of COVID-19 on pregnancy outcomes. This study aimed to report the maternal characteristics and clinical outcomes of pregnant women with COVID-19 disease. Study design This retrospective single-center study includes all consecutive pregnant women with confirmed (laboratory-confirmed) or suspected (according to version 7.0 of the Chinese management guideline) COVID-19 infection, regardless of gestational age at diagnosis, admitted to the Strasbourg University Hospital (France) from March 1 to April 3, 2020. Maternal characteristics, laboratory and imaging findings, and maternal and neonatal outcomes were extracted from medical records. Results The study includes 54 pregnant women with confirmed (n=38) and suspected (n=16) COVID-19 infection. Of these, 32 had an ongoing pregnancy, one a miscarriage, and 21 live births: 12 vaginal and 9 cesarean deliveries. Among the women who gave birth, preterm deliveries were medically indicated for their COVID-19-related condition for 23.8% (5/21): 14.3% (3/21) before 32 weeks' gestation and 9.5% (2/21) before 28 weeks. Oxygen support was required for 24.1% (13/54), including high flow oxygen (n=2), noninvasive (n=1) and invasive (n=3) mechanical ventilation, and extracorporeal membrane oxygenation (n=1). Of these, three, aged 35 years or older with positive COVID-19 RT-PCR, had respiratory failure requiring indicated delivery before 29 weeks' gestation. All three women were overweight or obese, and two had an additional comorbidity. Conclusion COVID-19 in pregnancy was associated with maternal morbidity and preterm birth. Its association with other well-known risk factors for severe maternal morbidity in noninfected pregnant women, including maternal age above 35 years, overweight, and obesity, suggests further studies are required to determine whether these risk factors are also associated with poorer maternal outcome in these women.

Since the beginning of the severe acute respiratory syndrome (SARS-CoV-2) or COVID-19 outbreak, it 80 has been argued that pregnant women are at increased risk of severe infection. 1, 2 Various experts 81 and authorities rapidly published articles of advice, guidance, and information to aid professionals in 82 caring for pregnant women infected by COVID-19. [3] [4] [5] [6] Most of the early reports, mainly from the 83 epicenter of the pandemic in China, 7-16 have suggested that pregnant women are not more severely 84 affected than the general population. 1, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Case reports and limited case series of pregnant women 85 from United States, 22 Iran, 2,3 and South America 24 have contradicted these reassuring preliminary 86 findings, however. They have instead described women with COVID-19 disease who require invasive 87 mechanical ventilation including extracorporeal membrane oxygenation (ECMO) and even maternal 88 death. These contradictory findings and the potential variation in disease severity between countries 89 means that additional information is urgently needed, especially from areas besides China, to 90 determine whether or not pregnant women with COVID-19 are likely to experience severe cases with 91 pneumonia. 92

We aim to present the clinical features and course of consecutive pregnant women with COVID-19 93 managed at a single French referral center, located in one of the main pandemic epicenters in 94

France. 95

This single-center retrospective study includes all consecutive pregnant women with COVID-19 98 infection, regardless of gestational age at diagnosis, admitted to Strasbourg University Hospital 99 (Strasbourg, France), a tertiary referral hospital, from March 1, 2020, to April 3, 2020. During the 100 study period, only symptomatic women were tested by qRT-PCR for COVID-19. Women with an 101 ongoing pregnancy and a time from illness onset to April 3 shorter than 14 days 25,26, were excluded. 102 COVID-19 infection was diagnosed according to the Chinese management guidelines (version 7·0), 26 103 which distinguishes confirmed cases, defined as all cases with respiratory tract samples tested 104 positive for SARS-CoV-2 by quantitative reverse transcription polymerase chain reaction (qRT-PCR), 105 from suspected cases, which include an epidemiological history (Strasbourg is a community with 106 numerous COVID-19 cases) and at least two of the following clinical manifestations: (i) fever and/or 107 respiratory syndrome, (ii) imaging features of COVID-19 pneumonia, and (iii) in early-stage disease, a 108 decreased or normal total number of leukocytes and lymphocyte counts. 26 The imaging features of 109 COVID-19 pneumonia used were typical radiographic features on chest computed tomography (CT), 110 owing to their high diagnostic sensitivity and accuracy for this diagnosis. 26-28 111 The Ethics Committee of Strasbourg University Hospital approved this study under a waiver of 112 informed consent (RNI 2020 -HUS N°7794). 113

Maternal characteristics, laboratory findings, CT scans, management, and maternal and fetal 115 outcomes were obtained from patients' medical records. 116

All laboratory tests were performed at Strasbourg University Hospital, including the laboratory 117 confirmation of SARS-CoV-2 by qRT-PCR tests for SARS-CoV2 nucleic acid on nasopharyngeal swabs. 29 118 Primer and probe sequences target two regions on the RdRp gene and are specific to SARS-CoV2. 119

Assay sensitivity is around 10 copies/reaction. For women with multiple RT-PCT assays, diagnosis of 120 COVID-19 was confirmed when any one nucleic acid test result was positive. Typical radiographic 121 features of COVID-19 on chest CT were consolidation, ground-glass opacity, or bilateral pulmonary 122 infiltration. 27 Neonatal throat and rectal swab samples were also collected for SARS-CoV-2 RT-PCR 123 assays at birth or on day 1, again on day 3 in term newborns , and also on days 7 and 14 in preterm 124 neonates. Skin-to-skin contact between mothers and neonates and breastfeeding were both 125 permitted at birth. 126

Definitions 127

Fever was defined as an axillary temperature of at least 37·8°C (100·0 F). The severity of COVID-19 128 was defined according to the Chinese management guidelines (version 7·0) as mild (mild clinical 129 symptoms and no sign of pneumonia), moderate (patients have fever and respiratory symptoms; 130 radiologic assessments found signs of pneumonia), severe (adults meeting any of the following 131 criteria: shortness of breath, respiratory rate 30 times/min or oxygen saturation ≤93% at rest or 132 alveolar oxygen partial pressure/fraction of inspiration 02 ≤ 300 mm Hg), and critical (any one or 133 more of mechanical ventilation, shock, or organ failure that needed intensive care unit (ICU) 134 monitoring and treatment). 26 one after and one before delivery. The latter subsequently required noninvasive mechanical 166 ventilation and has not yet given birth. Three more of the 13 women who received oxygen (23.1%) 167 subsequently had invasive mechanical ventilation in the postpartum. One (1.9%) woman later 168 required extracorporeal membrane oxygenation (ECMO). 169 Three (5.6%) received antiviral therapy (lopinavir/ritonavir 400 mg/100 mg twice a day for 5 days) 170 (Table 3) . 171

Among the 21 women who gave birth by April 17, 9 (42.9%) had cesarean and 12 (57.1%) vaginal 172 deliveries. The mean gestational age at delivery was 37.4 ± 4.7 weeks, but five women (23.8%) gave 173 birth before 37, three (14.3%) before 32 and two (9.5%) before 28 weeks' gestation. These five 174 premature births were medically indicated for severe maternal conditions related to COVID-19 175 infection, and two women were transferred to the ICU after delivery. Five women had postpartum 176 hemorrhages (9.3%), four (7.4%) necessitating a blood transfusion and one (1.9%) arterial 177 embolization. Five (9.3%) women were admitted to the ICU, all due to COVID-19 respiratory 178 symptoms. No thromboembolic event nor any other significant maternal morbidity occurred (Table  179 4). 180

No neonatal acidosis was observed, nor was there any fetal or neonatal death. Three neonates, two 181 born at 27 weeks' gestation and one at 28 weeks, underwent endotracheal intubation in the labor 182 ward and were admitted to the neonatal ICU for problems related to their extremely or very preterm 183 birth. All 21 neonates were tested for SARS-CoV-2 by RT-PCR of throat and rectal swab specimens, 184 and SARS-CoV-2 was never detected (Table 5) . 185

By the end of the follow-up (April 17), one woman (woman 2, Table S1) remained in the ICU, 27 days 186 after her transfer there. She had a secondary infection by Klebsiella pneumoniae and has required 187 ECMO since April 9. Another woman (woman 13, Table S1 ) remained hospitalized with an ongoing 188 pregnancy, but was transferred back to conventional care after six days in the ICU. She required high 189 flow oxygen therapy and transient noninvasive mechanical ventilation. All the other women have 190 been discharged from the hospital. Eighteen neonates were also discharged, healthy and with no 191 respiratory symptoms or fever. The remaining three newborns were still hospitalized for care related 192 to their prematurity. 193

The characteristics and clinical course of the 13 (24.1%) pregnant women with COVID-19 infection 195 who required oxygen support are described in Table S1 . All but three had lymphopenia (<1.0 × 10 9 196 cells per L) or elevated concentrations of C-reactive protein (>10 mg/L). Four of them were still 197 pregnant, while nine had had cesarean deliveries. Among the latter, three women aged 35 or older 198 with positive COVID-19 RT-PCR had medically indicated deliveries before 29 weeks' gestation due to 199 severe maternal respiratory symptoms. Before delivery, all three (women 1, 2, and 9) had respiratory 200 failure even though they were receiving 5 liters of oxygen per minute. Preterm delivery was decided 201 because physicians thought that maternal respiratory status would improve and oxygenation would 202 be facilitated after birth. 203

One of these women (woman 2) needed invasive mechanical ventilation and then ECMO after 204 delivery. All had at least one comorbidity: class III obesity (woman 1), overweight and gestational 205 hypertension (woman 2), and overweight and gestational diabetes mellitus (woman 9). 206 207 208

This is a descriptive study of the clinical characteristics and outcomes of 54 pregnant women with 211 either laboratory-confirmed (n=38) or suspected (n=16) COVID-19 infection; 32 pregnancies are 212 ongoing and 22 completed. Oxygen support was required for 24.1% (13/54) of pregnant women with 213 COVID-19 including 1.9% (1/54) who required ECMO, and 14.3% (3/21) of the births were very 214 preterm deliveries indicated for severe COVID-19-related maternal conditions. The latter three 215 women were aged 35 years or older, and all had at least one comorbidity. 216

Most of the data about the maternal, fetal, and neonatal outcomes of pregnant women infected by 218 COVID-19 have been globally reassuring. 7-21 Despite the unavailability of numerous details about 219 maternal characteristics, including body mass index and preexisting disease, or about the third stage 220 of labor, 7, 11, 14 the authors considered that the women's outcomes were "good" 13 or "satisfactory" 11 221 or that there is "no evidence to suggest that COVID-19 pneumonia causes severe maternal and 222 neonatal complications." 14 223

Zaigham and Andersson summarized these reports in a systematic review up to April 1 that included 224 108 pregnant women with COVID-19 from 18 case reports or series, mostly from China. 20 They 225 underlined that 3% (3/108) of the women were admitted to ICUs and noted that severe maternal 226 morbidity could therefore not be ruled out in COVID-19 infection during pregnancy, 20 Among these 43 women, 18 gave birth, 10 by uncomplicated vaginal deliveries and 8 by cesareans 251 for obstetric reasons unrelated to COVID. Nonetheless, two (4.7%) women were admitted to the 252 ICU. 18,19 The first was 38 years-old with a body mass index of 38 kg/m 2 , diabetes mellitus, and 253 intrahepatic cholestasis of pregnancy. Severe postpartum hemorrhage related to uterine atony 254 occurred during a cesarean that followed failed induction of labor. Because she had fever and 255 respiratory symptoms during delivery, a chest CT was performed and revealed ground-glass opacities 256 in the lungs. RT-PCR was subsequently positive for COVID-19. She spent only eight hours in ICU and 257 was discharged four days later. 18 The second woman admitted to the ICU was 33 years old, with a 258 body mass index of 47 kg/m 2 , chronic hypertension, type 2 diabetes mellitus, and mild intermittent 259 asthma. Twenty-five hours after a cesarean for failed induction of labor, she had coughing, 260 respiratory distress, high fever, and reduced oxygen saturation. Although her respiratory status 261 improved, she was admitted to the ICU after developing severe hypertension (blood pressure 262 reaching 200/90 mm Hg). RT-PCR showed COVID-19. After five days, when the report concluded, she 263 remained hospitalized, had acute kidney injury, and still needed oxygen supplementation. 18 In 264 neither of these cases, however, does COVID-19 infection appear to have been the -or at least the 265 only -reason for ICU admission, as the first case involved a severe postpartum hemorrhage and the 266 second severe hypertension. Nevertheless, no details were provided about any comorbidities related to these maternal deaths, 285 including body mass index. 23 Thus, due to the considerable methodological limitations of the latter 286 two reports, their principal information is that maternal deaths do occur in pregnant women infected 287 by COVID-19. 23,24 288

Our case series confirms that COVID-19 infection during pregnancy may be responsible for severe 290 maternal morbidity that may require very or extremely preterm elective delivery. In our series, 5.5% 291 of the women (3/54) had such medically indicated premature births, 24.1% (13/54) required oxygen 292 support, including invasive mechanical ventilation or ECMO for 5.5% (3/54), and 9.2% (5/54) were 293 admitted to the ICU. Interestingly, except for one of the two women who required ECMO and for 294 whom very few details were available, 11 the most severe cases reported came from countries outside 295

China, that is, from the United States, 18 France (our series), South America, 24 and Iran, 23 where 296 maternal characteristics and the prevalence of preexisting conditions may differ from those in China. 297

Most of the French and American women had one or more maternal characteristics that are known 298 to be associated with severe maternal morbidity in pregnant women, including an age of 35 years or 299 older, overweight or obesity, gestational hypertension or diabetes, and preexisting asthma. 31 These 300 new findings should alert physicians and help them to manage and follow up pregnant women with 301 COVID-19 infections. 302

Another interesting finding of our study is the high rate of postpartum hemorrhage (9.3%) and blood 303 transfusions (7.4%) observed in pregnant women with COVID-19, much higher than that reported in 304 the general population of pregnant women. 32 The literature thus far unfortunately fails to detail 305 these women's third stage of labor. 7-21 Despite the overall low numbers and the single limited 306 experience they come from, our findings warrant further investigation to examine whether COVID-19 307 infection might increase the risk of blood loss after delivery. Hemostasis changes may occur in these 308 women, especially as clinically significant coagulopathy with antiphospholipid antibodies has been 309 reported in nonpregnant patients with COVID-19 pneumonia. 33 310

Finally, all the neonates we tested were negative for COVID-19, consistently with previous reports, 7-21 311 although no conclusion can be drawn from our results about the possibility of intrauterine vertical 312 transmission. 313

Our retrospective study is one of the largest series of pregnant women with confirmed and 315 suspected cases of COVID-19 infection, and it provides the most detailed look at maternal 316 characteristics and maternal outcomes. It is one of the first to suggest that COVID-19 infection may 317 be responsible for severe maternal morbidity that can require medically indicated extremely preterm 318 delivery. Nevertheless, several limitations of our study must be underlined. The first is its 319 retrospective design, common to all the studies that have thus far assessed maternal outcome in 320 pregnant women with COVID-19. All the flaws of retrospective analyses apply. Moreover, the 321 reported rates should be interpreted cautiously; an overestimation of severe cases is possible as 322 Strasbourg University Hospital is the referral center for the management of pregnant women with 323 COVID-19 in the Alsace region. Moreover, generalizability is limited to regions with COVID-19 324 prevalence similar to that in the region where our hospital is located, which is one of the principal 325 pandemic hot spots in France (along with the Paris metropolitan region). Moreover, like previous 326 authors, 14, 15 we have included suspected cases with typical chest CT findings but with RT-PCR testing 327 negative for COVID-19, in accordance with the Chinese management guideline (version 7.0). 26 Given 328 the frequency of false negatives for COVID-19 cases, due to low virus titers, inappropriate swabbing 329 sites, and sampling at late disease stages, 34 as well as the limited testing capacity in France during our 330 study period (which also explains why only symptomatic women were tested during the study 331 period), limiting inclusion to laboratory-confirmed cases would likely result in missing some COVID-332 19 cases. 14 Nonetheless, all five women with premature births, including the three with the most 333 severe illness in our study, those that required indicated extremely or very preterm cesarean 334 delivery, had positive RT-PCR findings for COVID-19. Finally, even though our series is one of the 335 largest so far reported, the small sample size should be taken into account when interpreting the 336

Conclusions 338 COVID-19 infection may be associated with severe maternal outcomes with hypoxemic respiratory 339 failure despite oxygen support and can require an indicated -and sometimes very or extremely 340 preterm -delivery. Healthcare providers should be aware that many of the standard risk factors 341 associated with severe maternal morbidity without COVID-19 infection, such as maternal age above 342 35 years, overweight or obesity, preexisting and/or gestational hypertension or diabetes, may also 343 increase the risk of severe maternal morbidity for pregnant women infected by COVID 

Oxygen support (nasal cannula) 13 (24.1) High flow oxygen 2 (3.7) Non-invasive mechanical ventilation 1 (1.9) Invasive mechanical ventilation 3 (5.6)) Extracorporeal Membrane Oxygenation 1 (2.6) Antiviral therapy 3 (5.6) Antibiotic therapy 4 (7.4) Corticosteroid 0 Hydroxychloroquine/chloroquine 0

Five women had more than one oxygen support procedure: One had invasive mechanical ventilation and then extracorporeal membrane oxygenation; two had invasive mechanical ventilation; one received high flow oxygen. The last one received high flow oxygen and then required non-invasive mechanical ventilation. Pregnant women with ongoing pregnancy N= 32

Women who required admission to hospital due to COVID-19 infection N=1

Women who were discharged home N=31 * According to the Chinese management guideline for COVID-19 (version 7·0) 32 Age -years 30.6 ± 6.2 31.1 ± 6.4 29.6 ± 5.9

Age > 35 years -no. Table S1 ) had invasive mechanical ventilation and then extracorporeal membrane oxygenation; two (women 3 and 4, Table S1 ) had invasive mechanical ventilation; one (woman 7, Table S1 ) received high flow oxygen. The last one (woman 13, Table S1 ) received high flow oxygen and then required noninvasive mechanical ventilation. Delivery before 28 weeks' gestation -no./total no. (%) †, ‡ 2/21 (9.5%) 2/17 (11.8) 0 † Denominator was the number of pregnancies ended beyond the first trimester (n=21) ‡ Small-for-gestational-age was defined as birth weight less than the 10th percentile for gestational age and sex based on the French intrauterine growth curve ICU, intensive care unit CPAP, continuous positive airway pressure

Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to 347 a Rapidly Evolving Situation

2019-nCoV epidemic: what about pregnancies?

Practice advisory: novel coronavirus

Advisories/Practice-Advisory-Novel-Coronavirus2019

ISUOG Interim Guidance on 2019 novel coronavirus infection 355 during pregnancy and puerperium: information for healthcare professionals

Coronavirus Disease 2019 (COVID-360 19) and Pregnancy: What obstetricians need to know

Clinical characteristics and intrauterine vertical transmission 363 potential of COVID-19 infection in nine pregnant women : a retrospective review of medical 364 records

A case of 2019 Novel Coronavirus in a pregnant 366 woman with preterm delivery

Clinical analysis of 10 neonates born to mothers with 2019-nCoV 368 pneumonia

Clinical manifestations and outcome of SARS-CoV-2 infection during 370 pregnancy

Pregnancy and Perinatal Outcomes of 373 Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis

Clinical analysis of pregnant women with 2019 novel coronavirus 376 pneumonia

Clinical features and obstetric and neonatal outcomes of pregnant 378 patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet 379 Infect Dis

Maternal and neonatal outcomes of pregnant women with COVID-19 381 pneumonia: a case-control study

Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan

Coronavirus disease 2019 (COVID-19) in pregnant women: A report 386 based on 116 cases

COVID COVID COVID----19 in pregnancy was associated with 19 in pregnancy was associated with 19 in pregnancy was associated with 19 in pregnancy was associated with maternal morbidity and preterm maternal morbidity and preterm maternal morbidity and preterm maternal morbidity and preterm birth birth birth birth